A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia

Clinical trial NCT00793819 · COMPLETED

Trial details

NCT number: NCT00793819
Sponsor: Watson Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Nocturia Prostatic Hyperplasia

Start date: 2009-01-01
Primary completion: 2009-10-01
Enrollment: 215

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.